1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by NSAIDs Drug Revenue
1.4 Market by Type
1.4.1 Global NSAIDs Drug Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Ibuprofen
1.4.3 Naproxen
1.5 Market by Application
1.5.1 Global NSAIDs Drug Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Drugstores
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global NSAIDs Drug Market Perspective (2015-2026)
2.2 Global NSAIDs Drug Growth Trends by Regions
2.2.1 NSAIDs Drug Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 NSAIDs Drug Historic Market Share by Regions (2015-2020)
2.2.3 NSAIDs Drug Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 NSAIDs Drug Market Growth Strategy
2.3.6 Primary Interviews with Key NSAIDs Drug Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top NSAIDs Drug Players by Market Size
3.1.1 Global Top NSAIDs Drug Players by Revenue (2015-2020)
3.1.2 Global NSAIDs Drug Revenue Market Share by Players (2015-2020)
3.1.3 Global NSAIDs Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global NSAIDs Drug Market Concentration Ratio
3.2.1 Global NSAIDs Drug Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by NSAIDs Drug Revenue in 2019
3.3 NSAIDs Drug Key Players Head office and Area Served
3.4 Key Players NSAIDs Drug Product Solution and Service
3.5 Date of Enter into NSAIDs Drug Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global NSAIDs Drug Historic Market Size by Type (2015-2020)
4.2 Global NSAIDs Drug Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global NSAIDs Drug Market Size by Application (2015-2020)
5.2 Global NSAIDs Drug Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America NSAIDs Drug Market Size (2015-2020)
6.2 NSAIDs Drug Key Players in North America (2019-2020)
6.3 North America NSAIDs Drug Market Size by Type (2015-2020)
6.4 North America NSAIDs Drug Market Size by Application (2015-2020)
7 Europe
7.1 Europe NSAIDs Drug Market Size (2015-2020)
7.2 NSAIDs Drug Key Players in Europe (2019-2020)
7.3 Europe NSAIDs Drug Market Size by Type (2015-2020)
7.4 Europe NSAIDs Drug Market Size by Application (2015-2020)
8 China
8.1 China NSAIDs Drug Market Size (2015-2020)
8.2 NSAIDs Drug Key Players in China (2019-2020)
8.3 China NSAIDs Drug Market Size by Type (2015-2020)
8.4 China NSAIDs Drug Market Size by Application (2015-2020)
9 Japan
9.1 Japan NSAIDs Drug Market Size (2015-2020)
9.2 NSAIDs Drug Key Players in Japan (2019-2020)
9.3 Japan NSAIDs Drug Market Size by Type (2015-2020)
9.4 Japan NSAIDs Drug Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia NSAIDs Drug Market Size (2015-2020)
10.2 NSAIDs Drug Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia NSAIDs Drug Market Size by Type (2015-2020)
10.4 Southeast Asia NSAIDs Drug Market Size by Application (2015-2020)
11 India
11.1 India NSAIDs Drug Market Size (2015-2020)
11.2 NSAIDs Drug Key Players in India (2019-2020)
11.3 India NSAIDs Drug Market Size by Type (2015-2020)
11.4 India NSAIDs Drug Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America NSAIDs Drug Market Size (2015-2020)
12.2 NSAIDs Drug Key Players in Central & South America (2019-2020)
12.3 Central & South America NSAIDs Drug Market Size by Type (2015-2020)
12.4 Central & South America NSAIDs Drug Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Pfizer
13.1.1 Pfizer Company Details
13.1.2 Pfizer Business Overview
13.1.3 Pfizer NSAIDs Drug Introduction
13.1.4 Pfizer Revenue in NSAIDs Drug Business (2015-2020))
13.1.5 Pfizer Recent Development
13.2 GSK
13.2.1 GSK Company Details
13.2.2 GSK Business Overview
13.2.3 GSK NSAIDs Drug Introduction
13.2.4 GSK Revenue in NSAIDs Drug Business (2015-2020)
13.2.5 GSK Recent Development
13.3 Grunenthal
13.3.1 Grunenthal Company Details
13.3.2 Grunenthal Business Overview
13.3.3 Grunenthal NSAIDs Drug Introduction
13.3.4 Grunenthal Revenue in NSAIDs Drug Business (2015-2020)
13.3.5 Grunenthal Recent Development
13.4 Bayer
13.4.1 Bayer Company Details
13.4.2 Bayer Business Overview
13.4.3 Bayer NSAIDs Drug Introduction
13.4.4 Bayer Revenue in NSAIDs Drug Business (2015-2020)
13.4.5 Bayer Recent Development
13.5 Sanofi
13.5.1 Sanofi Company Details
13.5.2 Sanofi Business Overview
13.5.3 Sanofi NSAIDs Drug Introduction
13.5.4 Sanofi Revenue in NSAIDs Drug Business (2015-2020)
13.5.5 Sanofi Recent Development
13.6 Eli Lilly
13.6.1 Eli Lilly Company Details
13.6.2 Eli Lilly Business Overview
13.6.3 Eli Lilly NSAIDs Drug Introduction
13.6.4 Eli Lilly Revenue in NSAIDs Drug Business (2015-2020)
13.6.5 Eli Lilly Recent Development
13.7 AstraZeneca
13.7.1 AstraZeneca Company Details
13.7.2 AstraZeneca Business Overview
13.7.3 AstraZeneca NSAIDs Drug Introduction
13.7.4 AstraZeneca Revenue in NSAIDs Drug Business (2015-2020)
13.7.5 AstraZeneca Recent Development
13.8 Endo
13.8.1 Endo Company Details
13.8.2 Endo Business Overview
13.8.3 Endo NSAIDs Drug Introduction
13.8.4 Endo Revenue in NSAIDs Drug Business (2015-2020)
13.8.5 Endo Recent Development
13.9 Merck
13.9.1 Merck Company Details
13.9.2 Merck Business Overview
13.9.3 Merck NSAIDs Drug Introduction
13.9.4 Merck Revenue in NSAIDs Drug Business (2015-2020)
13.9.5 Merck Recent Development
13.10 Depomed
13.10.1 Depomed Company Details
13.10.2 Depomed Business Overview
13.10.3 Depomed NSAIDs Drug Introduction
13.10.4 Depomed Revenue in NSAIDs Drug Business (2015-2020)
13.10.5 Depomed Recent Development
13.11 Yunnan Baiyao
10.11.1 Yunnan Baiyao Company Details
10.11.2 Yunnan Baiyao Business Overview
10.11.3 Yunnan Baiyao NSAIDs Drug Introduction
10.11.4 Yunnan Baiyao Revenue in NSAIDs Drug Business (2015-2020)
10.11.5 Yunnan Baiyao Recent Development
13.12 Teva
10.12.1 Teva Company Details
10.12.2 Teva Business Overview
10.12.3 Teva NSAIDs Drug Introduction
10.12.4 Teva Revenue in NSAIDs Drug Business (2015-2020)
10.12.5 Teva Recent Development
13.13 J&J
10.13.1 J&J Company Details
10.13.2 J&J Business Overview
10.13.3 J&J NSAIDs Drug Introduction
10.13.4 J&J Revenue in NSAIDs Drug Business (2015-2020)
10.13.5 J&J Recent Development
13.14 Allergan
10.14.1 Allergan Company Details
10.14.2 Allergan Business Overview
10.14.3 Allergan NSAIDs Drug Introduction
10.14.4 Allergan Revenue in NSAIDs Drug Business (2015-2020)
10.14.5 Allergan Recent Development
13.15 Purdue
10.15.1 Purdue Company Details
10.15.2 Purdue Business Overview
10.15.3 Purdue NSAIDs Drug Introduction
10.15.4 Purdue Revenue in NSAIDs Drug Business (2015-2020)
10.15.5 Purdue Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
【掲載企業】
Pfizer、GSK、Grunenthal、Bayer、Sanofi、Eli Lilly、AstraZeneca、Endo、Merck、Depomed、Yunnan Baiyao、Teva、J&J、Allergan、Purdue
【免責事項】
https://www.globalresearch.jp/disclaimer